Evidence map›Paper›PMID 38384844›Full record

ArticleiScience2024

The role of cardiac remodeling associated with renal function in mediating cardiovascular event outcomes.

Zhi Lv, Yangzhi Fu, Chang Liu, Yao Ma, Miao Yuan, Junru Ren, Dengfeng Gao

Open access · goldAbstract read
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zhi LvDepartment of Cardiology, The Second Affiliated Hospital, Xi'an Jiaotong University, No. 157, West 5th Road, Xi'an 710004, Shaanxi, China.
Yangzhi FuWest China Hospital, Sichuan University, No 37, Guo Xue Xiang, Chengdu 610041, Sichuan, China.
Chang LiuDepartment of Cardiology, The Second Affiliated Hospital, Xi'an Jiaotong University, No. 157, West 5th Road, Xi'an 710004, Shaanxi, China.
Yao MaDepartment of Cardiology, The Second Affiliated Hospital, Xi'an Jiaotong University, No. 157, West 5th Road, Xi'an 710004, Shaanxi, China.
Miao YuanDepartment of Cardiology, The Second Affiliated Hospital, Xi'an Jiaotong University, No. 157, West 5th Road, Xi'an 710004, Shaanxi, China.
Junru RenThe Second Affiliated Hospital, Xi'an Jiaotong University, No. 157, West 5th Road, Xi'an 710004, Shaanxi, China.
Dengfeng GaoDepartment of Cardiology, The Second Affiliated Hospital, Xi'an Jiaotong University, No. 157, West 5th Road, Xi'an 710004, Shaanxi, China.
Second Affiliated Hospital of Xi'an Jiaotong University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The potential impact of renal function-related cardiovascular remodeling on associated cardiovascular risk has not been previously investigated. Hence, we conducted multiple mediation analyses in the UK Biobank study to evaluate this association. Using multiple Cox models, we found lower renal function (estimated glomerular filtration rate based on cystatin C, eGFR-cysC) was independently related to increased risks of various cardiovascular events and mortalities. Multivariable linear regression revealed a progressive relationship between declining eGFR-cysC and adverse left ventricular (LV) remodeling and impaired systolic function. In Cox models, larger LV volume, mass, as well as decreased systolic function, were significantly correlated with adverse events, particularly in heart failure. Mediation analyses showed that undesirable LV remodeling and cardiometabolic diseases were independent mediators. Our study explores the connections between reduced renal function and poor cardiovascular phenotypes, as well as their significant independent role in mediating renal function-cardiovascular outcome relationships.

Indexed as

Cardiovascular medicineHealth sciencesInternal medicineMedical specialtyMedicineNephrology

Identifiers

PMID38384844
PMCPMC10879695
OpenAlexW4391543051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.